Garner Asset Management Corp’s Novo Nordisk NVO Stock Holding History

Garner Asset Management Corp’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,572	Closed	-$80K	–	312
2025 Q4	$80K	Buy	+1,572	New	+$80.4K	0.03%	206
2024 Q3	–	Sell	-1,572	Closed	-$224K	–	152
2024 Q2	$224K	Sell	1,572 -8	-0.5%	-$1.06K	0.11%	140
2024 Q1	$203K	Hold	1,580	–	–	0.1%	149
2023 Q4	$186K	Buy	+1,580	New	+$156K	0.09%	140
2023 Q2	–	Sell	-2,740	Closed	-$218K	–	160
2023 Q1	$218K	Buy	+2,740	New	+$194K	0.1%	154

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Garner Asset Management Corp's NVO Position: Q1 2026 in Review

Garner Asset Management Corp sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 1,572 shares — an estimated $80K sold.

Garner Asset Management Corp first reported a position in NVO in Q1 2023 and held it in 5 quarters. The position peaked at $224K in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Garner Asset Management Corp reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Garner Asset Management Corp sold 1,572 Novo Nordisk shares in Q1 2026, an estimated $80K.
Garner Asset Management Corp first reported a position in Novo Nordisk in Q1 2023 and held it in 5 quarters.
Garner Asset Management Corp's Novo Nordisk position peaked at $224K in Q2 2024.
1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Garner Asset Management Corp's 13F filing for Q1 2026, filed 29 Apr 2026.